Back to User profile » Dr Ruilong Lu

Papers published by Dr Ruilong Lu:

Original Research

Effective-Component Compatibility of Bufei Yishen Formula Alleviates Alveolar Epithelial Barrier Damage in COPD Through Inhibition of p38 MAPK Phosphorylation

Shao X, Zhang L, Guo M, Wang C, Chu H, Mo Y, Lu R, Zhao P, Tian Y

International Journal of Chronic Obstructive Pulmonary Disease 2026, 21:589282

Published Date: 25 June 2026

Original Research

Effective Component Compatibility of Bufei Yishen Formula III Alleviates Pulmonary Vascular Inflammation in COPD: Via VEGF165/P38 MAPK Pathway

Song Q, Cui L, Lu R, Shao X, Xu K, Tian Y

Journal of Inflammation Research 2026, 19:523270

Published Date: 23 January 2026

Original Research

Effective-Component Compatibility of Bufei Yishen Formula III Protects Lung Air-Blood Barrier by Regulating the Oxidative Stress: via the Nuclear Factor-E2-Related Factor 2 Pathway

Xu K, Shao X, Lu R, Liao Y, Zhao Y, Wang B, Qiu Z, Tian Y

International Journal of Chronic Obstructive Pulmonary Disease 2025, 20:2211-2226

Published Date: 4 July 2025

Original Research

Effective-Component Compatibility of Bufei Yishen Formula III Suppresses Mitochondrial Oxidative Damage in COPD: Via Pkm2/Nrf2 Pathway

Liu Y, Zhang L, Zhao J, Lu R, Shao X, Xu K, Li J, Tian Y

International Journal of Chronic Obstructive Pulmonary Disease 2024, 19:1905-1920

Published Date: 24 August 2024